{
  "docId": "019dd923-5ca1-7489-b639-45501f4b359b",
  "docSlug": "158df8627a0b9aca",
  "documentTitle": "Opioid Conflicts Majority Staff Report",
  "authorId": "McKinsey",
  "authorName": "U.S. House Committee on Oversight and Reform",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "portrait",
  "aspectRatio": 0.773,
  "pageNumber": 41,
  "pageCount": 53,
  "prevPage": 40,
  "nextPage": 42,
  "slideType": "appendix_disclosure",
  "function": "cite_precedent",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "This appears to be a page from a formal investigative report or legal document, containing footnotes and an email excerpt.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "screenshot",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b639-45501f4b359b/41",
  "deckHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b#slide-41",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.7,
        "x": 0.15,
        "y": 0.27
      },
      "kind": "other",
      "text": "From: Alex Azar [Redacted] To: Martin Elling [martin_elling@mckinsey.com] Date: 02/06/2017 09:33 AM Subject: Connecting on job search ... [Email body text]",
      "attrs": null,
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4b216d13-edaa-4c9b-8036-b1dafe369400",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.7,
        "x": 0.15,
        "y": 0.64
      },
      "kind": "paragraph",
      "text": "On November 13, 2017, then-President Trump nominated Alex Azar to be the Secretary of Health and Human Services. On January 24, 2018, the Senate confirmed his nomination.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0ff57e18-fa1a-4c27-bc70-aa0ce1fea666",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.7,
        "x": 0.15,
        "y": 0.57
      },
      "kind": "paragraph",
      "text": "A meeting invitation obtained by the Committee indicates that May 1, 2017, Mr. Elling and other McKinsey consultants hosted Mr. Azar at McKinsey’s New York office “RE: Connecting on job search.”",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "31981b03-eac0-412d-9dbc-2c4acdf2f0b7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.7,
        "x": 0.15,
        "y": 0.69
      },
      "kind": "paragraph",
      "text": "According to documents obtained by the Committee, shortly thereafter, McKinsey consultants privately sent Secretary Azar a six-page transition memo entitled, “Setting the course for the US Department of Health and Human Services.”",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "748caf25-17fd-408b-a03a-9345a10d54ec",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.7,
        "x": 0.15,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "In January 2017, Alex Azar left his position as President of pharmaceutical company Eli Lilly and Company. Shortly thereafter, he emailed McKinsey consultant Martin Elling, a lead consultant for Purdue, for help with his job search.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b6d65255-d062-4cac-89d5-5739955bbc50",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "I’d really value sitting with you guys and talking through ideas you may have and advice on how to look at and for opportunities.",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd951-cdec-74db-b49d-afbd6b5e77df",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.7,
        "x": 0.15,
        "y": 0.78
      },
      "kind": "source-note",
      "text": "193-196: Citations regarding Azar's severance, McKinsey documents, and Trump's nomination.",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8c804868-e5be-4b8b-8abf-7fec2bb5503c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.7,
        "x": 0.15,
        "y": 0.11
      },
      "kind": "title",
      "text": "1. McKinsey Sent HHS Secretary Azar a Policy Memo Influenced by Consultants Working for Opioid Manufacturers and Had Previously Unknown Contacts with Secretary Azar",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ac8d54f6-a925-4b3b-9754-b0e5a2f141e3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 53,
      "from": 29,
      "beatId": "1170eac2-9202-4b41-a53c-edbd934ded10",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "The document concludes with implications of McKinsey's actions and potential next steps for regulatory action.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 53,
      "from": 1,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "ee9686db-f8b5-4bc9-bf6e-2d29966ee033",
      "evidence": "The document implies the cost of inaction through its presentation of McKinsey's conflicts of interest and their potential impact on the opioid epidemic.",
      "position": 0,
      "objective": "What is the cost of inaction in addressing McKinsey's conflicts of interest?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}